Panobinostat for the treatment of multiple myeloma: the evidence to date

by Bailey, Hanna, Stenehjem, David D, Sharma, Sunil
Published 2015

Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2

by Gill, David M, Stenehjem, David D, Parikh, Kinjal, Merriman, Joseph, Sendilnathan, Arun, Agarwal, Archana M, Hahn, Andrew W, Gupta, Sumati, Tantravahi, Srinivas Kiran, Samlowski, Wolfram E, Agarwal, Neeraj
Published 2016

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer – an observational cohort study

by Unni, Sudhir K., Schauerhamer, Marisa B., Deka, Rishi, Tyczynski, Jerzy E., Fernandes, Ancilla W., Stevens, Vanessa, Brixner, Diana I., Stenehjem, David D.
Published 2016

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer

by Stenehjem, David D, Yoo, Minkyoung, Unni, Sudhir K, Singhal, Mukul, Bauer, Hillevi, Saverno, Kim, Quah, Cheng, Masaquel, Anthony, Brixner, Diana I
Published 2014

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma

by Tantravahi, Srinivas K., Albertson, Daniel, Agarwal, Archana M., Ravulapati, Sowmya, Poole, Austin, Patel, Shiven B., Hawatmeh, Jamil S., Straubhar, Alli M., Liu, Ting, Stenehjem, David D., Agarwal, Neeraj
Published 2015